.The FDA approved DNDN to develop a new facility for provenge at LA.
Yesterday, final CMS approval was announced.
1) Final CMS approval for Provenge. (done)
2) Approval of LA manufacturing facility (done).
In a few weeks:
3) Approval of the Atlanta facility.Within the next couple of years:
4) European approval for manufacturing.
5) European manufacturing facilities completed.
6) An Asian deal for production
7) Full scale manufacturing from 3 operational plants in the USA, plus overseas manufacturing and revenue
.8) Test results for Neuvenge that might show application of the technology to other cancers.
Along the way, the roof will come off this puppy. There is no telling which BP might, along the way, bid very high for this company.Buy DNDN long, put it away, and retire well. Watch DNDN go to 45, then 50, then 65, then 85, then 100....onward to 300

Read MightyMo's blog in RSS


July 1, 2011
Edited: July 1, 2011
Share This